Anixa Biosciences, Inc.

Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Technologies
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Cancer Vaccines
      • Introduction
      • Markets
      • Science
      • Collaborators
    • COVID-19
      • Introduction
      • Science
      • Collaborators
  • Pipeline
  • Investors
    • Overview
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Publications
  • Contact Us

News Releases

Investors

Investors

  • Overview
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • RSS News Feed
  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

ITUS Will Hold Conference Call to Discuss its CAR-T Cancer Therapeutics Program

November 21, 2017

ITUS Enters CAR-T Research Alliance with Moffitt Cancer Center

November 20, 2017

ITUS Corporation Licenses CAR-T Technology from The Wistar Institute

November 14, 2017

ITUS Corporation Pays Off Secured Debenture

October 27, 2017

ITUS Receives Notice of NASDAQ Continued Listing Compliance

October 3, 2017

ITUS Corporation Completes At-the-Market Offering

October 2, 2017

ITUS Presentation to Annual Meeting of Stockholders

September 26, 2017

ITUS Corporation to Present at the 2017 Disruptive Growth Company Showcase NYC Presented by SeeThruEquity and RHK Capital

September 25, 2017

ITUS Provides Update on Cancer Detection Technology and New CAR-T Initiative for Ovarian Cancer

September 21, 2017

ITUS Corporation Announces Issuance of Patent on Cancer Detection Technology

September 18, 2017

RSS
  • « Previous
  • 1...
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • ...20
  • Next »

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

May 5, 2022

Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference

Read More...
Apr 28, 2022

Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting

Read More...
Apr 6, 2022

Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at The 4th International Workshop on CAR-T 2022

Read More...
Copyrights © 2022 Anixa Biosciences, Inc.. All Rights Reserved.
Privacy Policy Disclaimer Sitemap